文献速递呼吸道感染

便携式胸部X线作为COVID-19不良临床结局排除性检查

Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 Pandemic.
PubMed 文献 · Chest · 2021-01-29

在年龄<65岁且症状持续≥5天的955例患者中,胸片阴性者无死亡,阴性似然比更低,提示胸片阴性对不良结局有较强排除价值。

要点

  • 初始胸片阴性者后续住院、机械通气、ARDS和死亡风险低。
  • 年轻、合并症少、症状持续时间长的患者排除价值最高。
  • 在<65岁且症状≥5天者中,胸片阴性者无死亡。

核心结论

  • 初始胸片是疑似COVID-19成人患者住院、机械通气、ARDS和死亡的有力排除性检查。

主要发现

  • 胸片阴性预测住院的阴性似然比为0.27(95%CI,0.23-0.31),机械通气为0.24(95%CI,0.16-0.37),ARDS为0.19(95%CI,0.09-0.40),死亡为0.38(95%CI,0.29-0.51)。
  • 在955例年龄<65岁且症状持续≥5天的患者中,胸片阴性者无死亡,住院阴性似然比为0.17(95%CI,0.12-0.25),机械通气为0.09(95%CI,0.02-0.36),ARDS为0.09(95%CI,0.01-0.64)。

临床怎么用

  • 对疑似COVID-19成人,初始胸片阴性可降低对后续不良结局的担忧,尤其在年轻、合并症少、症状持续时间长的患者中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chest radiography (CXR) often is performed in the acute setting to help understand the extent of respiratory disease in patients with COVID-19, but a clearly defined role for negative chest radiograph results in assessing patients has not been described. RESEARCH QUESTION: Is portable CXR an effective exclusionary test for future adverse clinical outcomes in patients suspected of having COVID-19? STUDY DESIGN AND METHODS: Charts of consecutive patients suspected of having COVID-19 at five EDs in New York City between March 19, 2020, and April 23, 2020, were reviewed. Patients were categorized based on absence of findings on initial CXR. The primary outcomes were hospital admission, mechanical ventilation, ARDS, and mortality. RESULTS: Three thousand two hundred forty-five adult patients, 474 (14.6%) with negative initial CXR results, were reviewed. Among all patients, negative initial CXR results were associated with a low probability of future adverse clinical outcomes, with negative likelihood ratios of 0.27 (95% CI, 0.23-0.31) for hospital admission, 0.24 (95% CI, 0.16-0.37) for mechanical ventilation, 0.19 (95% CI, 0.09-0.40) for ARDS, and 0.38 (95% CI, 0.29-0.51) for mortality. Among the subset of 955 patients younger than 65 years and with a duration of symptoms of at least 5 days, no patients with negative CXR results died, and the negative likelihood ratios were 0.17 (95% CI, 0.12-0.25) for hospital admission, 0.09 (95% CI, 0.02-0.36) for mechanical ventilation, and 0.09 (95% CI, 0.01-0.64) for ARDS. INTERPRETATION: Initial CXR in adult patients suspected of having COVID-19 is a strong exclusionary test for hospital admission, mechanical ventilation, ARDS, and mortality. The value of CXR as an exclusionary test for adverse clinical outcomes is highest among young adults, patients with few comorbidities, and those with a prolonged duration of symptoms.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Pagano A, Finkelstein M, Overbey J, et al. Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 Pandemic. Chest. 2021. PMID: 33516703. doi:10.1016/j.chest.2021.01.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。